🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of ixazomi...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-01
Trial ID
NCT02917941
Treatments Being Tested
This research study is evaluating a combination of drugs considered standar...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2014-12
Trial ID
NCT02228772
Treatments Being Tested
The purpose of this study is to learn if Ixazomib maintenance treatment (ch...
Status
Active Not Recruiting
Location
Tufts Medical Center
Start Date
2018-08-02
Trial ID
NCT03618537
Treatments Being Tested
In this phase I study, escalating doses of IXAZOMIB will be combined with t...
Status
Withdrawn
Location
Froedtert & the Medical College of Wisconsin
Start Date
2017-06-29
Trial ID
NCT02578511
Treatments Being Tested
The main objective of this study is to evaluate the minimal residual diseas...
Status
Unknown
Location
CHU Bordeaux
Start Date
2018-12-31
Trial ID
NCT03669445
Treatments Being Tested
This is a multicenter, randomized, open-label, Phase 3 study comparing the ...
Status
Completed
Location
Local Institution - 109
Start Date
2019-04-16
Trial ID
NCT03651128
The main purpose of this study is to establish a safe and tolerable dose co...
Status
Withdrawn
Location
Columbia University Medical Center
Start Date
2020-11
Trial ID
NCT03880123
Multiple myeloma is an incurable blood cancer of plasma cells that occurs i...
Status
Completed
Location
Minsk Scientific Practical Center of Surgery, Transplantation and Hematology, Belarus
Start Date
2018-07-01
Trial ID
NCT03619252
Treatments Being Tested
This study will look at the safety and tolerability of the new drug MLN9708...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center
Start Date
2014-05-22
Trial ID
NCT02057640
Treatments Being Tested